Stock Market News

  • Britain's energy regulator Ofgem said on Thursday it was considering whether to reject a penalty exemption application for an electricity transmission joint venture between National Grid and SP Transmission.

  • seekingalpha.com
    seekingalpha.com icon

    YBIT shows relatively good income stability and capital preservation despite Bitcoin's volatility. YBIT's payout ratio is stable, with a robust 50% payout over the past 11 months, making it a viable option for monthly income stability. Investors looking for an income plan or exposure to bitcoin with a moderate risk return tradeoff can consider YBIT.

  • The Japanese operator of Uniqlo on Thursday said earnings soared 33% in its second quarter, the last period of calm before the U.S. imposition of import tariffs clouded the global clothing chain's aim for a fourth successive year of record profit.

  • seekingalpha.com
    seekingalpha.com icon

    AT&T's stock dip presents a strong buying opportunity for passive income investors, backed by robust free cash flow and a solid dividend yield above 4%. Fiber Broadband and 5G Mobility Services are driving growth, with AT&T expecting to triple its fiber connections by 2029 and hit record sales in Mobility Services in 2025. Free cash flow remains healthy, covering dividend payouts with room for future growth; the company forecasts $16B+ in FCF for 2025.

  • An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.

  • Capri Holdings, the owner of Michael Kors, Versace and Jimmy Choo, has seen its stock price in the dumps. Revenue declines, and poor profitability for Versace and Jimmy Choo, suggest that Capri's North American management have been unable to successfully fold these international brands into the main Kors business. CPRI stock recently tumbled as much as -40% on U.S. import tariff fears, and indeed the Michael Kors segment is highly exposed to tariffs.

  • Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has launched a new programme aimed at developing gene therapies for eye conditions, expanding the focus of its longevity research into ophthalmology. The London-listed biotech firm said on Thursday it will work on a treatment using its proprietary SIRT6 gene - a version found in people who live significantly longer than average - delivered to the eye using a specially engineered, non-viral system.

  • Tesco , Britain's biggest food retailer, warned on Thursday its profit would likely fall this year, reflecting a further increase in the "competitive intensity" of the UK market.

  • The highly disruptive and volatile environment will result in a 12-month delay for planned savings to be fully reflected in its bottom line.

  • Joby Aviation stock price remains in a deep bear market this year as investors wait for more details about its commercialization strategy. After initially soaring to a high of $10.73 on January 7, the stock has retreated by over 40% to the current $6.25.